{"name":"NeoMed","permalink":"neomed","crunchbase_url":"http://www.crunchbase.com/financial-organization/neomed","homepage_url":"http://www.neomed.net","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"","description":"","email_address":"","number_of_employees":null,"founded_year":1996,"founded_month":null,"founded_day":null,"tag_list":"","alias_list":"","created_at":"Tue Jun 16 08:40:26 UTC 2009","updated_at":"Thu Apr 05 00:25:01 UTC 2012","overview":"<p>NeoMed Management is an international investment firm, exclusively focussing on the healthcare and life science industry. Founded in 1996, NeoMed has established four funds, with total committed capital exceeding $200 million.</p>\n\n<p>NeoMed has a multi-stage investment approach and invests at all stages of development from start-up to later stage growth financings. Since inception, NeoMed has backed more than 30 companies in the USA and Europe, including Scandinavia, Switzerland, Germany and the UK.</p>","image":{"available_sizes":[[[150,59],"assets/images/resized/0006/1662/61662v2-max-150x150.jpg"],[[178,71],"assets/images/resized/0006/1662/61662v2-max-250x250.jpg"],[[178,71],"assets/images/resized/0006/1662/61662v2-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"","address1":"111 Devonshire Street, Suite 730","address2":"","zip_code":"02109","city":"Boston","state_code":"MA","country_code":"USA","latitude":null,"longitude":null}],"relationships":[],"investments":[{"funding_round":{"round_code":"a","source_url":"http://www.bio-medicine.org/biology-technology-1/Diagnoplex-Closes-CHF10-Million--28-248-3-Million-29-Series-A-Financing-9592-1/","source_description":"Diagnoplex Closes CHF10 Million ($8.3 Million) Series A Financing","raised_amount":8300000,"raised_currency_code":"USD","funded_year":2008,"funded_month":12,"funded_day":13,"company":{"name":"Diagnoplex","permalink":"diagnoplex","image":{"available_sizes":[[[150,40],"assets/images/resized/0004/8811/48811v1-max-150x150.jpg"],[[250,66],"assets/images/resized/0004/8811/48811v1-max-250x250.jpg"],[[326,87],"assets/images/resized/0004/8811/48811v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/endosense-sa-series-b-36m/","source_description":"Endosense, SA: Series B $36M","raised_amount":36000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":27,"company":{"name":"Endosense","permalink":"endosense","image":{"available_sizes":[[[150,60],"assets/images/resized/0006/3987/63987v2-max-150x150.png"],[[250,100],"assets/images/resized/0006/3987/63987v2-max-250x250.png"],[[264,106],"assets/images/resized/0006/3987/63987v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.kuros.ch/cms/upload/kuros_news/Jan_2005.pdf","source_description":"KUROS BIOSURGERY AG EXERCISES OPTION FOR CHF 6.1M (â‚¬ 4M) INVESTMENT","raised_amount":4000000,"raised_currency_code":"EUR","funded_year":2005,"funded_month":1,"funded_day":1,"company":{"name":"Kuros Biosurgery","permalink":"kuros-biosurgery","image":{"available_sizes":[[[106,150],"assets/images/resized/0009/9881/99881v1-max-150x150.jpg"],[[117,165],"assets/images/resized/0009/9881/99881v1-max-250x250.jpg"],[[117,165],"assets/images/resized/0009/9881/99881v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.kuros.ch/cms/upload/kuros_news/Oct_2005.pdf","source_description":"KUROS BIOSURGERY AG RAISES CHF 5.6M (â‚¬ 3.6M) IN ADDITIONAL FUNDING","raised_amount":3600000,"raised_currency_code":"EUR","funded_year":2005,"funded_month":10,"funded_day":1,"company":{"name":"Kuros Biosurgery","permalink":"kuros-biosurgery","image":{"available_sizes":[[[106,150],"assets/images/resized/0009/9881/99881v1-max-150x150.jpg"],[[117,165],"assets/images/resized/0009/9881/99881v1-max-250x250.jpg"],[[117,165],"assets/images/resized/0009/9881/99881v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.prnewswire.com/news-releases/novashunt-ag-raises-25-million-in-a-series-b-financing-co-led-by-biomedinvest-ag-entrepreneurs-fund-and-capricorn-health-tech-fund-117637818.html","source_description":"NovaShunt AG Raises $25 Million in a Series B Financing Co-Led by BioMedInvest AG, Entrepreneurs Fund and Capricorn Health-tech Fund","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":3,"funded_day":9,"company":{"name":"NovaShunt","permalink":"novashunt","image":{"available_sizes":[[[150,38],"assets/images/resized/0012/5630/125630v1-max-150x150.jpg"],[[250,64],"assets/images/resized/0012/5630/125630v1-max-250x250.jpg"],[[251,65],"assets/images/resized/0012/5630/125630v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}